Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
US |
|
P
|
Pebble Beach Systems Group PLC
F:VSF
|
UK |
|
U
|
Unilever PLC
VSE:ULVR
|
UK |
|
S
|
Siemens Healthineers AG
XMUN:SHL
|
DE |
|
S
|
Schibsted ASA
XMUN:XPG
|
NO |
|
T
|
Thor Industries Inc
F:TIV
|
US |
|
A
|
American Tower Corp
F:A0T
|
US |
|
V
|
Vale SA
SWB:CVLC
|
BR |
|
FILA Fabbrica Italiana Lapis ed Affini SpA
F:3S0
|
IT |
|
Amerisafe Inc
NASDAQ:AMSF
|
US |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
XMUN:AIL
|
FR |
|
VinFast Auto Ltd
F:0TL
|
SG |
|
Birkenstock Holding PLC
F:7PV
|
UK |
|
Oculis Holding AG
F:CR5
|
CH |
|
N
|
NSL Foods PCL
SET:NSL
|
TH |
|
F
|
Flowserve Corp
XMUN:FWV
|
US |
Wall St Price Targets
RYTM Price Targets Summary
Rhythm Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RYTM is 144.04 USD with a low forecast of 106.05 USD and a high forecast of 168 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RYTM's stock price target?
Price Target
144.04
USD
According to Wall Street analysts, the average 1-year price target for RYTM is 144.04 USD with a low forecast of 106.05 USD and a high forecast of 168 USD.
What is the Revenue forecast for Rhythm Pharmaceuticals Inc?
Projected CAGR
41%
The compound annual growth rate for Revenue over the next 8 years is 41%.
What is the Gross Profit forecast for Rhythm Pharmaceuticals Inc?
Projected CAGR
51%
The compound annual growth rate for Gross Profit over the next 6 years is 51%.
